首页> 美国卫生研究院文献>Cancer Science >Adeno‐associated Virus Vector Containing the Herpes Simplex Virus Thymidine Kinase Gene Causes Complete Regression of Intracerebrally Implanted Human Gliomas in Mice in Conjunction with Ganciclovir Administration
【2h】

Adeno‐associated Virus Vector Containing the Herpes Simplex Virus Thymidine Kinase Gene Causes Complete Regression of Intracerebrally Implanted Human Gliomas in Mice in Conjunction with Ganciclovir Administration

机译:含有单纯疱疹病毒胸苷激酶基因的腺相关病毒载体与更昔洛韦联合给药可导致小鼠大脑内植入的人胶质瘤完全消退

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adeno‐associated virus (AAV) has attracted considerable interest as a potential vector for gene therapy because of its wide host range, high transduction efficiency, and lack of cytopathogenicity. In this experiment, we evaluated the efficacy of AAV vector containing the herpes simplex virus thymidine kinase (HSV‐tk) gene on human gliomas transplanted into the brain of nude mice. Complete regression of the tumors was observed after multiple AAV‐tk injections followed by intraperitoneal ganciclovir (GCV) administration, and the survival of mice treated with AAV‐tk vector and GCV administration was markedly prolonged. These results suggest that AAV‐tk vectors may be useful for gene therapy against malignant gliomas in humans.
机译:腺伴随病毒(AAV)具有广泛的宿主范围,高转导效率和缺乏细胞致病性,作为基因治疗的潜在载体引起了广泛的关注。在本实验中,我们评估了包含单纯疱疹病毒胸苷激酶(HSV-tk)基因的AAV载体对移植到裸鼠脑中的人神经胶质瘤的功效。多次注射AAV-tk和腹膜内更昔洛韦(GCV)给药后,观察到肿瘤完全消退,用AAV-tk载体和GCV给药治疗的小鼠的存活期显着延长。这些结果表明,AAV-tk载体可用于针对人类恶性神经胶质瘤的基因治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号